CQS (US)’s Merck MRK Stock Holding History

CQS (US)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-292,182	Closed	-$21.5M	–	126
2020 Q1	$21.5M	Buy	+292,182	New	+$23M	1.58%	23

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CQS (US)'s MRK Position: Q2 2020 in Review

CQS (US) sold out of Merck (MRK) in Q2 2020, closing a stake of 292,182 shares — an estimated $21.5M sold.

CQS (US) first reported a position in MRK in Q1 2020 and held it in 1 quarter. The position peaked at $21.5M in Q1 2020. 2,495 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

CQS (US) reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
CQS (US) sold 292,182 Merck shares in Q2 2020, an estimated $21.5M.
CQS (US) first reported a position in Merck in Q1 2020 and held it in 1 quarter.
CQS (US)'s Merck position peaked at $21.5M in Q1 2020.
2,495 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on CQS (US)'s 13F filing for Q2 2020, filed 7 Aug 2020.